STOCK TITAN

Iradimed Stock Price, News & Analysis

IRMD NASDAQ

Company Description

Company Overview

Iradimed Corp (IRMD) is a specialized medical device company that designs, manufactures, markets, and distributes MRI-compatible technologies. The company is renowned for its innovations in non-magnetic system design, chiefly offering an intravenous (IV) infusion pump system and patient vital signs monitoring systems that operate safely in strong magnetic fields. As a major developer within the healthcare technology arena, Iradimed provides essential solutions that address the inherent risks associated with traditional electronic infusion devices used in MRI environments.

Core Technology and Innovation

At the heart of Iradimed's offerings is its pioneering approach to MRI compatibility. The company has engineered a non-magnetic IV infusion pump system that eliminates the hazards presented by conventional infusion pumps in the presence of strong magnets. By utilizing non-ferrous components, specialized ultrasonic motors, and innovative design principles, Iradimed minimizes radio frequency interference and ensures patient safety during critical imaging procedures. Additionally, its state-of-the-art patient vital signs monitoring systems are built to operate reliably within intense magnetic fields, ensuring continuous monitoring without interruption.

Products and Systems

Iradimed’s product portfolio is built around its specialized MRI-compatible devices, which include:

  • IV Infusion Pump System: Designed specifically for use in MRI environments, this system safely delivers fluids, anesthesia, and medications without the risks associated with magnetic interference.
  • Patient Vital Signs Monitoring System: Engineered to accurately monitor heart rate, blood pressure, respiratory parameters, and oxygen saturation, this system supports continuous patient monitoring even within strong magnetic fields.
  • Accessory Ecosystem: Complementary products such as disposable tubing sets, IV poles, wireless remote displays/controls, and dose error reduction systems enhance the functionality and safety of the primary devices.

Each system is engineered with an emphasis on reliability, precision, and ease of use, reaffirming Iradimed’s commitment to enhancing patient safety and clinical efficiency.

Market and Distribution

The company serves a diverse clientele including hospitals, acute care facilities, and outpatient imaging centers. Iradimed leverages direct field sales teams, regional sales directors, clinical support representatives, and independent distributors to ensure its innovative products are accessible across a wide range of healthcare settings. Its insights into market dynamics and clinical needs drive the continuous improvement and validation of its technology, making Iradimed a trusted partner in the healthcare community.

Competitive Landscape and Differentiation

In an industry where safety and reliability are paramount, Iradimed distinguishes itself by focusing on the unique challenges posed by MRI environments. Unlike competitors that offer conventional infusion systems susceptible to magnetic interference, Iradimed’s products are engineered to meet the rigorous demands of MRI procedures. The company’s commitment to maintaining stringent safety and operational standards underlies its positioning within the competitive landscape, underpinning its reputation as a technology innovator in the medical device sector.

Significance in Healthcare

The introduction of MRI-compatible technologies is a transformative step in managing critical care scenarios where uninterrupted treatment is essential. Iradimed’s systems assure that patients undergoing MRI scans, including sensitive cases such as pediatric or critically ill patients, receive continuous care without compromising image quality or safety. With a focus on operability in high-magnetic environments, Iradimed contributes significantly to reducing procedure-related risks and improving overall patient outcomes.

Innovation and Safety Focus

Driven by a robust research and development agenda, Iradimed continues to refine its technologies by integrating cutting-edge design with clinical insights. The company firmly believes in combining innovation with rigorous safety protocols, ensuring that every product not only meets but often exceeds industry standards. Its systems, designed with specialized non-magnetic components, are a testament to its relentless pursuit of advancing medical technology in a way that aligns with the critical needs of modern healthcare providers.

Operational Excellence and Distribution Strategy

Iradimed’s operational model is anchored in a direct-to-market approach that enhances product accessibility and customer support. Through an extensive network of dedicated sales professionals and independent distributors, the company maintains a strong market presence both in the United States and internationally. This strategic model facilitates prompt product deployment, efficient customer service, and sustained after-sale support, which together reinforce its reputation for operational excellence.

Conclusion

In summary, Iradimed Corp stands as a pivotal innovator in the realm of MRI-compatible medical devices. By focusing intently on innovation, safety, and precise engineering, the company addresses significant challenges associated with MRI procedures. Its comprehensive product portfolio, commitment to quality, and integrated market strategy not only broaden its impact on healthcare environments but also build a foundation of trust and authority within the industry. Investors and healthcare professionals alike can view Iradimed as a key player in advancing the standards of patient care through specialized medical technology.

Stock Performance

$53.32
0.00%
0.00
Last updated: April 27, 2025 at 16:00
28.57 %
Performance 1 year
$658.3M
Market Cap
12.7M
Shares outstanding

SEC Filings

No SEC filings available for Iradimed.

Financial Highlights

$73,242,121
Revenue (TTM)
$19,234,026
Net Income (TTM)
$1.50
Diluted EPS (TTM)
$25,624,463
Operating Cash Flow
26.26%
Net Profit Margin
29.99%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Iradimed (IRMD)?

The current stock price of Iradimed (IRMD) is $53.32 as of April 25, 2025.

What is the market cap of Iradimed (IRMD)?

The market cap of Iradimed (IRMD) is approximately 658.3M.

What is the revenue (TTM) of Iradimed (IRMD) stock?

The trailing twelve months (TTM) revenue of Iradimed (IRMD) is $73,242,121.

What is the net income of Iradimed (IRMD)?

The trailing twelve months (TTM) net income of Iradimed (IRMD) is $19,234,026.

What is the earnings per share (EPS) of Iradimed (IRMD)?

The diluted earnings per share (EPS) of Iradimed (IRMD) is $1.50 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Iradimed (IRMD)?

The operating cash flow of Iradimed (IRMD) is $25,624,463.

What is the profit margin of Iradimed (IRMD)?

The net profit margin of Iradimed (IRMD) is 26.26%.

What is the operating margin of Iradimed (IRMD)?

The operating profit margin of Iradimed (IRMD) is 29.99%.

What is the gross margin of Iradimed (IRMD)?

The gross profit margin of Iradimed (IRMD) is 76.94%.

What is the current ratio of Iradimed (IRMD)?

The current ratio of Iradimed (IRMD) is 8.84, indicating the company's ability to pay short-term obligations.

What is the gross profit of Iradimed (IRMD)?

The gross profit of Iradimed (IRMD) is $56,349,881 on a trailing twelve months (TTM) basis.

What is the operating income of Iradimed (IRMD)?

The operating income of Iradimed (IRMD) is $21,964,727.

What does Iradimed Corp specialize in?

Iradimed Corp specializes in developing and manufacturing MRI-compatible medical devices, including non-magnetic IV infusion pumps and advanced patient monitoring systems.

How does Iradimed ensure the safety of its devices during MRI procedures?

The company employs non-ferrous components and specialized design techniques to eliminate magnetic interference, ensuring that its devices can operate safely in strong magnetic fields during MRI scans.

Which healthcare settings benefit from Iradimed's products?

Iradimed's products are widely used in hospitals, acute care facilities, and outpatient imaging centers, supporting safe and effective patient care during MRI procedures.

What are the core technologies behind Iradimed's products?

The core technologies include non-magnetic ultrasonic motors, specialized design of infusion pump systems, and reliable patient monitoring systems that function accurately within high magnetic fields.

How does the company distribute its products?

Iradimed utilizes a mix of direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors to effectively reach its target markets.

How are Iradimed's products different from conventional medical devices?

Unlike conventional devices, Iradimed's products are designed with specialized non-magnetic components and technology that prevent radio frequency interference, ensuring safe operation during MRI procedures.

What role does innovation play in Iradimed's business model?

Innovation is central to Iradimed's approach, as it continuously refines its technology to enhance patient safety and operational efficiency in challenging MRI environments.

Why is MRI compatibility important in modern healthcare?

MRI compatibility is critical because it minimizes risks associated with magnetic interference, ensuring that patients receive uninterrupted care and accurate monitoring during imaging procedures.